Durgical
EN
Open the app

Clonality testing: telling lymphoma from a reactive response

  • Topic

A normal immune response uses many different lymphocytes; a lymphoma is one lymphocyte copied over and over, and the lab can prove which it is.

Updated

What it is

Clonality tests ask whether a population of lymphocytes comes from many cells (polyclonal, usually reactive) or from one cell (monoclonal, suggesting a neoplasm). Flow cytometry looks for light-chain restriction and abnormal marker patterns, molecular tests look for a single rearranged immunoglobulin or T-cell receptor gene, and serum tests look for a monoclonal protein. Results are always read together with the morphology and the clinical picture.

Key facts

  • Clonal expansions can occur in benign settings (some viral infections, ageing T cells, MGUS), so clonality alone is not cancer.
  • Polyclonal hypergammaglobulinaemia suggests chronic infection, liver disease or autoimmunity; a monoclonal spike suggests a plasma-cell disorder.
  • Next-generation sequencing of a clone’s receptor gene can track minimal residual disease after treatment.

Step by step

  1. An enlarged node or abnormal blood count raises the question of lymphoma or leukaemia.
  2. Tissue is obtained, ideally by excisional or core biopsy so the architecture can be seen.
  3. Flow cytometry checks κ:λ ratio of B cells and aberrant phenotypes (for example CD5 on B cells, loss of CD7 on T cells).
  4. Immunohistochemistry maps markers and architecture (CD20, CD3, CD10, BCL2, cyclin D1, Ki-67).
  5. PCR or sequencing of IGH or TCR genes looks for one dominant rearrangement.
  6. FISH or karyotype finds characteristic translocations (t(14;18), t(11;14), MYC).
  7. The pathologist integrates morphology, phenotype and molecular results into a diagnosis.

Clonality clues by method

MethodPolyclonal (reactive)Monoclonal (suspicious)
Flow cytometry (B cells)Mixed κ and λ light chainsOnly κ or only λ (light-chain restriction)
Flow cytometry (T cells)Normal antigen pattern, mixed Vβ familiesLoss of CD7 or other antigens, single Vβ family
PCR of IGH / TCR genesMany sizes (smear or Gaussian curve)One dominant peak or band
Serum protein electrophoresis and immunofixationBroad polyclonal rise of gamma globulinsNarrow M spike of one heavy and one light chain
Serum free light chainsNormal κ/λ ratioAbnormal κ/λ ratio

Common traps

  • A monoclonal result means cancer: small benign clones occur in MGUS, some infections and ageing, so clonality only supports a diagnosis read with morphology.
  • A high κ:λ ratio means κ cells are healthy and dominant: either extreme ratio (only κ or only λ) is light-chain restriction and signals one clone.
  • Polyclonal hypergammaglobulinaemia suggests myeloma: a broad gamma rise is reactive (infection, liver disease, autoimmunity), myeloma gives a narrow M spike.
  • A fine-needle aspirate is enough to call lymphoma: architecture matters, so an excisional or core biopsy is preferred.

Test yourself

Think of the answer, then tap the question to see it.

Flow cytometry of a lymph node shows B cells that all express λ light chain. What does this mean and why?

Light-chain restriction: each B cell uses only κ or λ, so a population that is all λ came from one cell, a clonal (likely neoplastic) expansion.

Why does PCR of IGH genes give a smear in a reactive node but a single peak in lymphoma?

Each B clone has a different-length V(D)J junction; many clones give many sizes, one clone gives one dominant size.

An older adult has a small IgG-κ M spike, normal blood counts and no organ damage. Is this myeloma?

Not necessarily: a small clone without end-organ damage fits MGUS, which is monitored; clonality alone is not cancer.

Add to my cards (3)

Elsewhere in DurgiPedia

Connections

← All of immunology

Educational content on the immune system; not a treatment or individual vaccination guide and no substitute for a health professional's advice. No doses are given.

Sources: Immune response (MedlinePlus, US National Library of Medicine, 2024); ELISA blood test (MedlinePlus, US National Library of Medicine, 2024).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.